Changes in atherosclerotic cardiovascular disease risk over time among people living with HIV

Author:

Chen Weisi1,Petoumenos Kathy1,Somia Agus2,Edmiston Natalie3,Chaiwarith Romanee4,Woolley Ian5ORCID,Ross Jeremy6,Pujari Sanjay7,Boettiger David C1ORCID, ,Khol V,Ouk V,Pov C,Penh Phnom,Zhang F J,Zhao H X,Han N,Lee M P,Li P C K,Kwong T S,Li T H,Kumarasamy N,Ezhilarasi C,Pujari S,Joshi K,Gaikwad S,Chitalikar A,Borse R T,Mave V,Marbaniang I,Nimkar S,Somia I K A,Merati T P,Sawitri A A S,Yuliana F,Yunihastuti E,Widhani A,Maria S,Karjadi T H,Tanuma J,Oka S,Nishijima T,Choi J Y,S N a,Kim J M,Gani Y M,Rudi N B,Azwa I,Kamarulzaman A,Omar S F Syed,Ponnampalavanar S,Ditangco R,Pasayan M K,Mationg M L,Chen H P,Chan Y J,Wu P F,Ke E,Ng O T,Lim P L,Lee L S,Yap T,Avihingsanon A,Gatechompol S,Phanuphak P,Phadungphon C,Kiertiburanakul S,Phuphuakrat A,Chumla L,Sanmeema N,Chaiwarith R,Sirisanthana T,Praparattanapan J,Nuket K,Khuwuwan S,Kambua P,Pongrapass S,Limlertchareonwanit J,Pham T N,Nguyen K V,Nguyen D T H,Nguyen D T,Do C D,Ngo A V,Nguyen L T,Sohn A H,Ross J L,Petersen B,Law M G,Jiamsakul A,Rupasinghe D,Ellis D,Bloch M,Allen D,Burton L,Baker D,Mousavi R,Farlow H,Byrne E,Templeton D J,Garton L,Doyle T,Jackson Eva,Ryder N,Sweeney G,Moran B,Carr A,Hesse K,Hawkes A,Finlayson R,Shields M,Burdon R,Calleia P,Brown K,Varma R,Bopage R,Walsh J,Varghese S,Chung C,Smith D E,Cogle A,Lawrence C,Mulhall B,Law M,Petoumenos K,Hutchinson J,Rose N,Dougherty T,Byonanebye D,Han A,Rupasinghe D,Russell D,Rodriguez M,Sowden D,Taing K,Broom J,Dennien S,Orth D,Youds D,Priscott E,Benn S,Griggs E,Roth N J,Lau H,Teague R,Silvers J,Zeng W,Levey A,Hoy J,Giles M,Bryant M,Price S,Harris P Rawson,Woolley I,Korman T,O’Bryan J,Cisera K,Raymond N

Affiliation:

1. Kirby Institute, UNSW Sydney , Sydney , Australia

2. Department of Tropical and Infectious Diseases, Udayana University , Denpasar , Indonesia

3. School of Medicine, Rural Research, Western Sydney University , Sydney , Australia

4. Department of Internal Medicine, Faculty of Medicine, Chiang Mai University , Chiang Mai , Thailand

5. Monash Infectious Diseases, Monash Health and Monash University , Melbourne , Australia

6. TREAT Asia, amfAR—The Foundation for AIDS Research , Bangkok , Thailand

7. Institute of Infectious Diseases , Pune , India

Abstract

Abstract Objective To describe changes in atherosclerotic cardiovascular disease (ASCVD) risk over time among people living with HIV (PLHIV). Methods We used data from the TREAT Asia HIV Observational Database (TAHOD) and the Australian HIV Observational Database (AHOD). Five-year ASCVD risk was calculated using the D:A:D equation. Individuals were eligible for inclusion if they were aged ≥18 years, had started ART, had no previous history of ASCVD and had complete ASCVD risk factor data available within the first 5 years of ART initiation. Results A total of 3368 adults contributed data, 3221 were from TAHOD and 147 were from AHOD. The median age at ART initiation was 36 [IQR 31–43] years for TAHOD participants, and 42 [IQR 35–50] years for AHOD participants. Most TAHOD (70.4%) and AHOD (91.8%) participants were male. Overall, ASCVD risk increased from 0.84% (95% CI 0.81%–0.87%) at ART initiation to 1.34% (95% CI 1.29%–1.39%) after 5 years on ART. After adjusting for traditional and HIV-associated ASCVD risk factors, ASCVD risk increased at a similar rate among sub-populations defined by HIV exposure (heterosexuals, men who have sex with men, people who inject drugs), race/ethnicity (Caucasian and Asian) and nadir CD4 at ART initiation (<200 and ≥200 cells/mm3). Conclusions These findings emphasize the growing burden of ASCVD risk among PLHIV and the need to develop interventions that are effective across a broad range of HIV sub-populations.

Funder

National Institute of Allergy and Infectious Diseases

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Institute of Diabetes and Digestive and Kidney Diseases

Australian Government Department of Health and Ageing

UNSW Sydney

Publisher

Oxford University Press (OUP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3